Agenus Inc. - Common Stock (NQ:AGEN)
8.088
+0.268
(+3.42%)
Streaming Delayed Price
Updated: 12:57 PM EDT, Aug 4, 2026
Add to My Watchlist
All News about Agenus Inc. - Common Stock
Botensilimab/Balstilimab Clinical Responses in Refractory Sarcomas Presented at ESMO 2024
September 13, 2024
From Agenus Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
Agenus Inc. - Common Stock (NQ:AGEN)
8.088
+0.268
(+3.42%)
Streaming Delayed Price
Updated: 12:57 PM EDT, Aug 4, 2026
Add to My Watchlist
All News about Agenus Inc. - Common Stock
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|